Secondary specific aims are to assess safety and tolerability of vitamin D supplementation; variation of response to vitamin D supplementation among subgroups defined by key baseline characteristics; variation by level of adherence; effect of vitamin D supplementation on glycemic measures, insulin resistance and secretion, blood pressure, and blood 25OHD concentration; and phenotypic characteristics associated with variation in achieved blood 25OHD concentration.